Bali Z, Nagy L, Budai D, Hernadi I. Facilitation and inhibition of firing activity and N-methyl-D-aspartate-evoked responses of CA1 hippocampal pyramidal cells by alpha7 nicotinic acetylcholine receptor selective compounds in vivo. Sci Rep. 2019;9:9324 pubmed publisher

Bali Z, Bruszt N, Tadepalli S, Csurgyók R, Nagy L, Tompa M, et al. Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats. Front Pharmacol. 2019;10:73 pubmed publisher

Foucault Fruchard L, Doméné A, Page G, Windsor M, Emond P, Rodrigues N, et al. Neuroprotective effect of the alpha 7 nicotinic receptor agonist PHA 543613 in an in vivo excitotoxic adult rat model. Neuroscience. 2017;356:52-63 pubmed publisher

Sérrière S, Doméné A, Vercouillie J, Mothes C, Bodard S, Rodrigues N, et al. Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model. Front Med (Lausanne). 2015;2:61 pubmed publisher

Bali Z, Inkeller J, Csurgyók R, Bruszt N, Horváth H, Hernádi I. Differential effects of α7 nicotinic receptor agonist PHA-543613 on spatial memory performance of rats in two distinct pharmacological dementia models. Behav Brain Res. 2015;278:404-10 pubmed publisher

Macpherson A, Zoheir N, Awang R, Culshaw S, Ramage G, Lappin D, et al. The alpha 7 nicotinic receptor agonist PHA-543613 hydrochloride inhibits Porphyromonas gingivalis-induced expression of interleukin-8 by oral keratinocytes. Inflamm Res. 2014;63:557-68 pubmed publisher

Wang Q, Wang F, Li X, Yang Q, Li X, Xu N, et al. Electroacupuncture pretreatment attenuates cerebral ischemic injury through ?7 nicotinic acetylcholine receptor-mediated inhibition of high-mobility group box 1 release in rats. J Neuroinflammation. 2012;9:24 pubmed publisher